Jump to navigation
The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).
The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.
Our meeting has been changed to virtual. The meeting weblink will be posted just prior to the meeting for public attendees.
1:00 p.m. - 5:00 p.m.
The Committee meets once quarterly in January, April, July, and October.
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
Zoom Webinar – Registration Link: https://magellanhealth.zoom.us/webinar/register/WN_djrylmPdQLCujiUzy3QA1w
Our meeting has a new location: 303 E. 17th Ave, Denver, Colorado 80203
The Board meets once quarterly in January, April, July, and October
MEETING WILL TAKE PLACE ON THE 11TH FLOOR IN CONFERENCE ROOMS 11ABC
The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.
January 2020 - December 2021 Term
Lynn Parry, MD
Gwen Black, PharmD
Marisa Wiktor, MD
Kelet Robinson, MD
Thuy McKitrick, PharmD
Davin Patel, PharmD
January 2021 - December 2022 Term
James Feinstein, MD
Kimberley Jackson, DO
David Elwell, MD
Emily Kosirog, PharmD
Daralyn Morgenson, PharmD
Interested parties who want to present at the meeting shall give at least 3 business days notice (by 5 p.m. MST), prior to the meeting, to Jessica Czechowski, Clinical Account Manager, by email at jlczechowski@magellanhealth.com and carbon copy Brittany Schock, PDL Pharmacist, by email at brittany.schock@state.co.us. Please see the specific deadline for testimony on the meeting agenda.
Please see the P&T Committee Policies and Procedures for both written and verbal comments.
Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.
